Use of a pharmaceutical formulation comprising trimagnesium dicitrate salt or trimagnesium dicitrate, to treat pathological calcifications including arteriosclerosis, where the compounds are present in hydrate or anhydrate form

Use of a pharmaceutical formulation comprising trimagnesium dicitrate salt or trimagnesium dicitrate, to treat pathological calcifications including arteriosclerosis, where the compounds are present in hydrate or anhydrate form

Use of a pharmaceutical formulation (I) comprising trimagnesium dicitrate salt or trimagnesium dicitrate as an active agent, to treat pathological calcifications including arteriosclerosis, is claimed, where the compounds: in the formulation can exist alone or in combination and are present in hydra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: LIEDTKE, RAINER K
Format: Patent
Sprache:eng ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Use of a pharmaceutical formulation (I) comprising trimagnesium dicitrate salt or trimagnesium dicitrate as an active agent, to treat pathological calcifications including arteriosclerosis, is claimed, where the compounds: in the formulation can exist alone or in combination and are present in hydrate or anhydrate form. ACTIVITY : Antiarteriosclerotic. MECHANISM OF ACTION : None given. Die Erfindung beschreibt die Verwendung pharmazeutischer Formulierungen von Trimagnesiumdicitrat und Trimagnesiumdiisocitrat-Salzen zur Behandlung pathologischer Calcifizierungen bei Arteriosklerose.